Rare Diseases and Orphan Drugs

Biography

Christoph Wachsmuth has done his PhD in molecular biology and at present he is the Senior Medical Science Liaison Manager Hematology/Rare Diseases at Takeda Germany (after Shire was taken over by Takeda and he worked under Disease Areas: Hemophilia A and B, von-Willebrand-Disease, Thrombotic-thrombocytopenic purpura (TTP), Gene therapy HämA (AAV5-based) on KOL management, identification, development and Scientific literature update, Organisation of AdBoards, Support of Clinical Studies Phase II-III, Implementation of Takeda Hemophilia Academy, Support of Patients-Organisations North-Germany Hemophilia, Training and support of 6 KAMs.. & He is the Senior Medical Science Liaison Manager Oncology at Shire Deutschland GmbH (after Baxalta was taken over by Shire) Disease Areas and Molecules,Gastroenterology-oncology: Pancreatic cancer (Nal-IRI, Onivyde); Myelofibrosis (pacritinib, JAK2/FLT3-inhibitors), Hematology (ALL, AML; Peg-aspargase, Oncaspar), CAR-T-therapy; NorthgermanyKOL management, identification, development

Research Interest

Rare Diseases